ATE377654T1 - Ubiquitin-ligase-assay - Google Patents

Ubiquitin-ligase-assay

Info

Publication number
ATE377654T1
ATE377654T1 AT01924655T AT01924655T ATE377654T1 AT E377654 T1 ATE377654 T1 AT E377654T1 AT 01924655 T AT01924655 T AT 01924655T AT 01924655 T AT01924655 T AT 01924655T AT E377654 T1 ATE377654 T1 AT E377654T1
Authority
AT
Austria
Prior art keywords
ubiquitin ligase
ligase assay
assay
assays
relates
Prior art date
Application number
AT01924655T
Other languages
English (en)
Inventor
Sarkiz Issakani
Jianing Huang
Julie Sheung
Todd Pray
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE377654T1 publication Critical patent/ATE377654T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
AT01924655T 2000-04-03 2001-04-03 Ubiquitin-ligase-assay ATE377654T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/542,497 US6740495B1 (en) 2000-04-03 2000-04-03 Ubiquitin ligase assay

Publications (1)

Publication Number Publication Date
ATE377654T1 true ATE377654T1 (de) 2007-11-15

Family

ID=24164065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01924655T ATE377654T1 (de) 2000-04-03 2001-04-03 Ubiquitin-ligase-assay

Country Status (9)

Country Link
US (5) US6740495B1 (de)
EP (1) EP1268847B1 (de)
JP (1) JP4095805B2 (de)
AT (1) ATE377654T1 (de)
AU (1) AU2001251291A1 (de)
DE (1) DE60131262T2 (de)
DK (1) DK1268847T3 (de)
ES (1) ES2296744T3 (de)
WO (1) WO2001075145A2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7378248B2 (en) * 2000-03-06 2008-05-27 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein-protein interaction
US6979551B2 (en) * 2000-04-03 2005-12-27 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US6740495B1 (en) * 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
US20020028472A1 (en) * 2000-06-29 2002-03-07 Michael Gmachl Methods for identifying inhibitors of the anaphase promoting complex
US20040241694A1 (en) 2001-09-07 2004-12-02 Heinz Von Der Kammer Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
WO2003043580A2 (en) * 2001-11-19 2003-05-30 Proteologics, Inc. Methods for identifying and validating potential drug targets
US7723018B2 (en) 2002-08-30 2010-05-25 Rigel Pharmaceuticals, Incorporated Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
EP1867731A3 (de) 2002-08-30 2008-03-12 Rigel Pharmaceuticals, Inc. Verfahren zum Testen von Modulatoren von Entzündungsprozessen über Teile der Ubiquitinbindungskaskade
US7736846B2 (en) * 2002-08-30 2010-06-15 Rigel Pharmaceuticals, Inc. Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
US7052843B2 (en) 2002-10-08 2006-05-30 New York University Transcription-based assay for identification of post-translational modification and its application in proteomics
US7312197B2 (en) * 2003-02-24 2007-12-25 University Of Maryland, Baltimore Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
US20070122807A1 (en) * 2003-04-03 2007-05-31 Proteologics, Inc. Posh polypeptides, complexes and related methods
WO2005000876A2 (en) * 2003-06-27 2005-01-06 Proteologics, Inc. Ring finger family proteins and uses related thereto
US7132234B2 (en) * 2003-10-28 2006-11-07 Rigel Pharmaceuticals, Inc. Methods and compositions for the identification of anti-poxvirus agents
WO2005047476A2 (en) * 2003-11-10 2005-05-26 Rigel Pharmaceuticals, Inc. Inhibition of retroviral replication through modulation of the host cell ubiquitylation
EP1595945A1 (de) * 2004-05-14 2005-11-16 Boehringer Ingelheim International GmbH Screeningverfahren zur Identifizierung von Verbindungen, die die Wirkung von Myc inhibieren können.
JP2008517278A (ja) * 2004-10-15 2008-05-22 シグナル ファーマシューティカルズ，エルエルシー ｐ２７のユビキチン化アッセイ及びその使用方法
AU2005311680A1 (en) * 2004-12-01 2006-06-08 Proteologics, Inc. Ubiquitin ligase assays and related reagents
PL1838350T3 (pl) 2005-01-20 2015-02-27 Ryboquin Company Ltd Modulatory aktywności ubikwitynazy itch
US20060246543A1 (en) * 2005-03-03 2006-11-02 President And Fellows Of Harvard College Slim compositions and methods of use thereof
US20070060537A1 (en) * 2005-04-28 2007-03-15 Proteologics, Inc. Methods and compositions for inhibiting viral infections
ATE494548T1 (de) * 2005-06-02 2011-01-15 Univ North Carolina Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase
US9066976B2 (en) 2005-11-11 2015-06-30 Korea Research Institute Of Bioscience And Biotechnology Method for therapeutic angiogenesis
KR100877824B1 (ko) * 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
US8058014B2 (en) * 2006-09-29 2011-11-15 University Of Maryland, Baltimore Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2
KR20090090383A (ko) 2006-12-14 2009-08-25 다이이찌 산쿄 가부시키가이샤 이미다조티아졸 유도체
WO2008106087A1 (en) * 2007-02-28 2008-09-04 The Brigham And Women's Hospital, Inc. Compositions and methods for identifying factors affecting protein stability
US7892772B2 (en) * 2007-03-12 2011-02-22 Iti Scotland Limited Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins
MX344557B (es) 2007-05-08 2016-12-20 Hunter Douglas Ind Switzerland Sistema de color multivariado con aplicacion de textura.
DE112008002458T5 (de) 2007-09-14 2011-06-01 Basf Plant Science Gmbh Pflanzen mit erhöhten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben
FR2924721B1 (fr) * 2007-12-10 2010-02-26 Cytomics Systems Procede de criblage d'agents modulant l'activite de l'ubiquitine ligase mdm2 et moyens destines a la mise en oeuvre dudit procede
ES2509890T3 (es) * 2008-04-29 2014-10-20 Cornell University Sustancias y composiciones para potenciar la reparación de ADN y procedimientos de uso
US20090269731A1 (en) * 2008-04-29 2009-10-29 Burnham Institute For Medical Research E3-independent ubiquitinylation assay
EP2298778A4 (de) 2008-06-12 2011-10-05 Daiichi Sankyo Co Ltd Imidazothiazolderivat mit 4,7-diazaspiro[2.5]octan-ringstruktur
JP2011528908A (ja) * 2008-07-25 2011-12-01 プロジェンラ インク． ユビキチンリガーゼのモジュレーターの特定法
WO2010042828A2 (en) * 2008-10-09 2010-04-15 The Penn State Research Foundation Methods and compositions relating to e3 ring-e2 fusion proteins
SG173028A1 (en) 2009-01-16 2011-08-29 Daiichi Sankyo Co Ltd Imidazothiazole derivative having proline ring structure
US20130131153A1 (en) * 2009-11-16 2013-05-23 The Johns Hopkins University Cullin 5 as a regulator of hsp90 clients: a new target for drug development
KR101873199B1 (ko) 2010-01-12 2018-08-03 아람 바이오시스템 주식회사 3단 열대류 장치 및 그 사용법
GB201006604D0 (en) 2010-04-20 2010-06-02 Iti Scotland Ltd Ubiquitination assay
GB201007185D0 (en) 2010-04-29 2010-06-09 Iti Scotland Ltd Ubiquitination assay
EP2575849A4 (de) * 2010-06-01 2014-03-05 Univ Ben Gurion Schnelle synthese ubiquitinierter peptidkonjugate
US9383367B1 (en) 2010-12-07 2016-07-05 Chunli Liu Methods of detecting conjugation site-specific and hidden epitope/antigen
DK2684880T3 (en) 2011-03-10 2018-05-22 Daiichi Sankyo Co Ltd DISPIROPYRROLIDINE DERIVATIVES
WO2013042120A2 (en) 2011-09-19 2013-03-28 Proteologics Ltd Synthetic ubiquitins and use thereof in drug screening assays
RU2666530C2 (ru) * 2012-01-12 2018-09-11 Йейл Юниверсити Соединения и способы усиления деградации белков-мишеней и других полипептидов с помощью е3 убиквитин лигазы
US20150111205A1 (en) * 2012-01-18 2015-04-23 Singular Bio Inc. Methods for Mapping Bar-Coded Molecules for Structural Variation Detection and Sequencing
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
GB201311891D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compound
GB201311888D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
WO2015077058A2 (en) 2013-11-08 2015-05-28 The Broad Institute, Inc. Compositions and methods for selecting a treatment for b-cell neoplasias
US20180228907A1 (en) 2014-04-14 2018-08-16 Arvinas, Inc. Cereblon ligands and bifunctional compounds comprising the same
US10071164B2 (en) 2014-08-11 2018-09-11 Yale University Estrogen-related receptor alpha based protac compounds and associated methods of use
WO2016138574A1 (en) 2015-03-02 2016-09-09 Sinai Health System Homologous recombination factors
EP3347717A4 (de) 2015-09-11 2019-06-05 The Brigham and Women's Hospital, Inc. Verfahren zur charakterisierung der resistenz gegen modulatoren von cereblon
RU2018120330A (ru) 2015-11-02 2019-12-04 Йейл Юниверсити Химерные соединения, осуществляющие нацеливание для протеолиза, и способы их получения и применения
US11604186B2 (en) * 2018-10-17 2023-03-14 Molecular Devices (Austria) GmbH Real time western blot assays utilizing fluorescence resonance energy transfer (FRET)
CN111208243B (zh) * 2018-11-21 2022-05-17 中国科学院大连化学物理研究所 一种基于阴离子交换色谱柱的sumo化肽段的富集方法
WO2022187342A1 (en) * 2021-03-02 2022-09-09 The Board Of Regents Of The University Of Texas System Methods and compositions for detecting protein targets
EP4437343A4 (de) * 2021-11-23 2025-12-31 Univ Texas Fret-aktive e2-ubl-konjugate und verwendungen davon

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
GB9214857D0 (en) 1992-07-13 1992-08-26 Medical Res Council Human nucleic acid fragments and their use
US5384255A (en) * 1993-06-21 1995-01-24 Rappaport Family Institute For Research In The Medical Sciences Ubiquitin carrier enzyme E2-F1, purification, production, and use
US5744343A (en) * 1994-01-04 1998-04-28 Mitotix, Inc. Ubiquitin conjugating enzymes
WO1995018974A2 (en) * 1994-01-04 1995-07-13 Mitotix, Inc. Ubiquitin conjugating enzymes
JPH10500842A (ja) * 1994-03-31 1998-01-27 ザ ユニバーシティ オブ リーズ ユビキチン結合酵素をコードするｄｎａ
US6127158A (en) * 1994-12-07 2000-10-03 President And Fellows Of Harvard College Ubiquitin conjugating enzymes
US5726025A (en) * 1995-04-20 1998-03-10 President And Fellows Of Harvard College Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell cycle regulatory proteins
US6001619A (en) * 1995-10-04 1999-12-14 Cold Spring Harbor Laboratory Ubiquitin ligases, and uses related thereto
US5861249A (en) * 1996-04-23 1999-01-19 Cold Spring Harbor Laboratory Assays and reagents for identifying modulators of cdc25-mediated mitotic activation
US5840866A (en) * 1996-07-10 1998-11-24 Incyte Pharmaceuticals, Inc. Human ubiquitin-conjugating enzyme
EP0843008A1 (de) 1996-11-14 1998-05-20 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von dem Anaphase-fördernden Komplex
US5817494A (en) * 1997-05-21 1998-10-06 Incyte Pharmaceuticals, Inc. Ubiquitin conjugation proteins
US6060262A (en) * 1997-07-16 2000-05-09 Mitotix, Inc. Regulation of I Kappa B (IκB) degradation and methods and reagents related thereto
EP1367124A1 (de) 1997-08-01 2003-12-03 Genset 5' Ests für sekretierte Proteine, die im Muskel und anderen mesodermalen Geweben exprimiert werden
DK1000151T3 (da) 1997-08-01 2006-10-02 Serono Genetics Inst Sa 5'EST'er for secernerede proteiner udtrykt i forskellige væv
AU9664598A (en) * 1997-09-23 1999-04-12 Incyte Pharmaceuticals, Inc. Human ubiquitin-conjugating enzymes
US6573094B1 (en) * 1997-10-16 2003-06-03 Baylor College Of Medicine F-box genes and proteins
US6426205B1 (en) * 1997-10-24 2002-07-30 Mount Sinai Hospital Corporation Methods and compositions for modulating ubiquitin dependent proteolysis
US5968747A (en) * 1997-12-12 1999-10-19 Incyte Pharmaceuticals, Inc. Ubiquitin-like conjugating protein
NZ503417A (en) 1997-12-19 2002-12-20 Warner Lambert Co Use of SAG (sensitive to apoptosis gene) in protecting cells from apoptosis
GB9727277D0 (en) 1997-12-23 1998-02-25 Medical Res Council Assay
US6165731A (en) * 1998-01-22 2000-12-26 California Institute Of Technology Assay for the ubiquitination-promoting activity of human proteins
US5976849A (en) * 1998-02-05 1999-11-02 Zeneca Limited Human E3 ubiquitin protein ligase
US6413725B1 (en) * 1998-08-07 2002-07-02 California Institute Of Technology Biochemical assay to monitor the ubiquitin ligase activities of cullins
US6331396B1 (en) * 1998-09-23 2001-12-18 The Cleveland Clinic Foundation Arrays for identifying agents which mimic or inhibit the activity of interferons
US7223556B1 (en) 1998-10-09 2007-05-29 President And Fellows Of Harvard College Targeted proteolysis by recruitment to ubiquitin protein ligases
US6306663B1 (en) * 1999-02-12 2001-10-23 Proteinex, Inc. Controlling protein levels in eucaryotic organisms
JP2002538088A (ja) 1999-02-25 2002-11-12 サイクラセル・リミテッド 天然結合パートナーの修飾をモニターするための組成物および方法
EP1155030A4 (de) 1999-02-26 2005-12-14 Oklahoma Med Res Found Verbindung des hippel-lindau-tumorsuppressionskomplexes und scf ubiquitin ligase
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
CA2364305A1 (en) 1999-03-31 2000-10-05 The University Of North Carolina At Chapel Hill Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same
JP2001192152A (ja) * 2000-01-11 2001-07-17 Fuji Photo Film Co Ltd 給紙マガジン
US6740495B1 (en) * 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
WO2001097830A1 (en) 2000-06-22 2001-12-27 Mount Sinai School Of Medicine Modification of mdm2 activity
EP1167539A1 (de) 2000-06-29 2002-01-02 Boehringer Ingelheim International GmbH Verfahren zur Identifizierung von Verbindungen die das Anaphae-fördernde Komplex hemmen
US6526205B1 (en) * 2000-10-13 2003-02-25 Agilent Technologies, Inc. Method and apparatus for the passive alignment of optical components
DE10108263A1 (de) 2001-02-21 2002-09-05 Max Planck Gesellschaft Analyse von Modifizierungen und Demodifizierungen von Proteinen mit Ubiquitinverwandten Proteinen mittels FRET (Fluorescence Resonance Energy Transfer)

Also Published As

Publication number Publication date
US20090263831A1 (en) 2009-10-22
US6737244B2 (en) 2004-05-18
US20060105409A1 (en) 2006-05-18
WO2001075145A3 (en) 2002-07-25
US6740495B1 (en) 2004-05-25
WO2001075145A2 (en) 2001-10-11
AU2001251291A1 (en) 2001-10-15
US7022493B2 (en) 2006-04-04
EP1268847B1 (de) 2007-11-07
US20050032139A1 (en) 2005-02-10
DK1268847T3 (da) 2008-03-10
JP4095805B2 (ja) 2008-06-04
DE60131262T2 (de) 2008-08-28
US7781182B2 (en) 2010-08-24
US20020042083A1 (en) 2002-04-11
ES2296744T3 (es) 2008-05-01
DE60131262D1 (en) 2007-12-20
JP2003529372A (ja) 2003-10-07
EP1268847A2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
ATE377654T1 (de) Ubiquitin-ligase-assay
PT1086076E (pt) Inibidores de sulfonamida de aspartil protease
BR0317715A (pt) Composições e processos de uso de collajolie
WO2004020458A3 (en) Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents
EP1474093A4 (de) Granzym-b-hemmer
TR200002877T2 (tr) Sülfonamid türevleri
DE60039481D1 (de) Schnittstelle zur Übertragung von Fehlersuchinformation
BR0316324A (pt) Polipeptìdeos e conjugados de interferon-alfa
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
IL179441A0 (en) Hif prolyl hydroxylase activity assay
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
BRPI0515079A (pt) marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados
WO2004048935A3 (en) Detection of protease enzymes
FR2816843B1 (fr) Inhibiteurs de l'enzyme 5 alpha-reductase
NO20034951D0 (no) En analyse for å påvise inhibitorer av enzymet myeloperoksidase
EP1381349A4 (de) Tyrosinasebestimmung
DK1147420T3 (da) Urintrypsininhibitor til diagnosticering af AIDS
EP1589033A4 (de) Antikörper und dessen verwendung
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
DE60225587D1 (de) Protease assay zur kontrolle medikamentöser therapie
DE50105492D1 (de) Hefestamm zur prüfung der geno- und zytotoxizität komplexer umweltkontaminationen
DE60324259D1 (de) Reagens zur messung der aktivität von alaninaminotransferase
ATE360704T1 (de) Neuartige peroxidasesubstrate und ihre anwendung in katalysierten reporterbindungsassays
DE60118350D1 (de) Fluoreszenz-verfahren zum nachweis von proteasen oder peptidasen
DE69936359D1 (de) Reagenz zum Assay von Amylase-Isoenzymaktivität

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1268847

Country of ref document: EP